The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationThe Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies
Barber, R., Gholkar, A., Scheltens, P., Ballard, C., McKeith, I. G., & O’Brien, J. T. (1999) · Neurology · doi:10.1212/wnl.52.6.1153 · Cited by 210
Self-citation
Research works printed but not linked: 71
- Aarsland, 1999, Donepezil for dementia with Lewy bodies: A case study, Int J Geriatr Psychiatr, 14, 69, 10.1002/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO;2-C · doi:10.1002/(sici)1099-1166(199901)14:1<69::aid-gps888>3.0.co;2-c
- Aarsland, 1999, Neuropsychiatric aspects of Parkinson's disease, Curr Psychiatr Rep, 1, 61, 10.1007/s11920-999-0011-3 · DOI
- Aarsland, 1999, Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease: A community-based study, Arch Neurol, 56, 595, 10.1001/archneur.56.5.595 · DOI · Paper page
- Agid, 1994, Neuronal basis of mental impairment in parkinsonian syndromes, Behav Neurol, 7, 5
- Arai, 1994, Apolipoprotein E gene in Parkinson's disease with or without dementia, Lancet, 344, 889, 10.1016/S0140-6736(94)92862-2 · DOI
- Ayre, 1996, Psychological function in dementia with Lewy bodies and senile dementia of Alzheimer's type, Neurobiol Aging, 17, 205, 10.1016/S0197-4580(96)80207-7 · doi:10.1016/s0197-4580(96)80207-7
- Ballard, 1993, Idiopathic clouding of consciousness: Do the patients have cortical Lewy body disease?, Int J Geriatr Psychiatr, 8, 571, 10.1002/gps.930080707 · DOI
- Ballard, 2000, One year follow-up of parkinsonism in dementia with Lewy bodies, Dementia and Geriatric Cognitive Disorders, 11, 219, 10.1159/000017240 · DOI
- Ballard, 1998, A prospective study of dementia with Lewy bodies, Age Ageing, 27, 631, 10.1093/ageing/27.5.631 · DOI
- Barber, 1999, White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging, J Neurol Neurosurg Psychiatr, 67, 66, 10.1136/jnnp.67.1.66 · DOI · Paper page
- Birkett, 1992, Lewy bodies in psychiatric patients, Int J Geriatr Psychiatr, 7, 235, 10.1002/gps.930070404 · DOI
- Briel, 1999, EEG findings in dementia with Lewy bodies and Alzheimer's disease, J Neurol Neurosurg Psychiatr, 66, 401, 10.1136/jnnp.66.3.401 · DOI · Paper page
- Dickson, 1994, Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease, Acta Neuropathol, 87, 269, 10.1007/BF00296742 · DOI
- Gnanalingham, 1997, Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer's and Parkinson's diseases, J Neurol Neurosurg Psychiatr, 62, 243, 10.1136/jnnp.62.3.243 · DOI · Paper page
- Goetz, 1998, Intravenous levodopa in hallucinating Parkinson's disease patients: High dose challenge does not precipitate hallucinations, Neurology, 50, 515, 10.1212/WNL.50.2.515 · DOI · Paper page
- Gomez-Tortosa, 1999, Clinical and quantitative pathological correlates of dementia with Lewy bodies, Neurology, 53, 1284, 10.1212/WNL.53.6.1284 · DOI · Paper page
- Haeske-Dewick, 1995, Hallucinations in Parkinson's disease: Characteristics and associated clinical features, Int J Geriatr Psychiatr, 10, 487, 10.1002/gps.930100608 · DOI
- Hansen, 1993, Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa, J Neuropathol Exp Neurol, 52, 648, 10.1097/00005072-199311000-00012 · DOI · Paper page
- Harrison, 1995, Senile dementia of Lewy body type: A review of clinical and pathological features: Implications for treatment, Int J Geriatr Psychiatr, 10, 919, 10.1002/gps.930101103 · DOI
- Hassler, 1938, Zur pathologie der paralysis agitans und des postenzephalitischen Parkinsonismus, J Psychologie Neurologie, 48, 387
- Higuchi, 1998, Diagnostic assessment and neuropathological correlates of cerebral metabolic changes in dementia with Lewy bodies: PET and postmortem brain studies, Neurobiol Aging, 19, S205
- Holmes, 1999, Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies, Br J Psychiatr, 174, 45, 10.1192/bjp.174.1.45 · DOI · Paper page
- Hutchinson, 1996, Cholinesterase inhibitors in Parkinson's disease, J Neurol Neurosurg Psychiatr, 61, 324, 10.1136/jnnp.61.3.324-a · DOI
- Iwanaga, 1999, Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases, Neurology, 52, 1269, 10.1212/WNL.52.6.1269 · DOI · Paper page
- Jellinger, 1996, Structural basis of dementia in neurodegenerative disorders, J Neural Transm, 47, 1, 10.1007/978-3-7091-6892-9_1 · DOI
- Jellinger, 1995, Structural basis of mental impairment in Parkinson's disease, Neuropsychiatrie, 9, 9
- Kaufer, 1998, Dementia with Lewy bodies: Response of delirium-like features to donepezil, Neurology, 51, 1512, 10.1212/WNL.51.5.1512 · DOI
- Klatka, 1996, Psychiatric features in diffuse Lewy body disease: Findings in 28 pathologically diagnosed cases, Neurology, 46, A180
- Kosaka, 1998, Recent advances in dementia research in Japan: Non-Alzheimer type degenerative dementias, Psychiatr Clin Neurosci, 52, 367, 10.1046/j.1440-1819.1998.00402.x · DOI
- Kosaka, 1984, Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: A new disease?, Clin Neuropathol, 3, 185
- Kuzuhara, 1993, Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly, Adv Neurol, 60, 464
- Lennox, 1989, Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry, J Neurol Neurosurg Psychiatr, 52, 1236, 10.1136/jnnp.52.11.1236 · DOI · Paper page
- Litvan, 1998, Accuracy of the clinical diagnoses of Lewy body disease, Parkinson's disease, and dementia with Lewy bodies, Arch Neurol, 55, 969, 10.1001/archneur.55.7.969 · DOI · Paper page
- Louis, 1997, Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease, Neurology, 48, 376, 10.1212/WNL.48.2.376 · DOI · Paper page
- Luis, 1999, Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample, Int J Geriatr Psychiatr, 14, 526, 10.1002/(SICI)1099-1166(199907)14:7<526::AID-GPS965>3.0.CO;2-0 · DOI
- McKeith, 1992, Neuroleptic sensitivity in patients with senile dementia of Lewy body type, Br Med J, 305, 673, 10.1136/bmj.305.6855.673 · DOI · Paper page
- McKeith, 1998, Dementia with Lewy bodies: Clinical and pathological diagnosis, Alzheimer Rep, 1, 83
- McKeith, 1995, Neuroleptic sensitivity to risperidone in Lewy body dementia, Lancet, 346, 699, 10.1016/S0140-6736(95)92307-1 · DOI
- McKeith, 2000, Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies, Neurology, 54, 1050, 10.1212/WNL.54.5.1050 · DOI · Paper page
- McKeith, 2000, Rivastigmine in the treatment of dementia with Lewy bodies, Int J Geriatr Psychiatr, 15, 387, 10.1002/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9 · doi:10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9
- McKeith, 1996, Apolipoprotein E genotyping in Alzheimer's disease, Lancet, 347, 1775, 10.1016/S0140-6736(96)90857-0 · DOI
- McKeith, 1999, Diagnosing dementia with Lewy bodies, Lancet, 354, 1227, 10.1016/S0140-6736(99)90214-3 · DOI
- McKeith, 1999, Report of the second dementia with Lewy body international workshop, Neurology, 53, 902, 10.1212/WNL.53.5.902 · DOI · Paper page
- McKeith, 1992, Operational criteria for senile dementia of Lewy body type (SDLT), Psychol Med, 22, 911, 10.1017/S0033291700038484 · DOI · Paper page
- McShane, 1995, Prospective study of relations between cortical Lewy bodies, poor eyesight and hallucinations in Alzheimer's disease, J Neurol Neurosurg Psychiatr, 59, 185, 10.1136/jnnp.59.2.185 · DOI
- McShane, 1998, Prospective evaluation of diagnostic criteria for dementia with Lewy bodies, Neurobiol Aging, 19, S204
- Mega, 1996, Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria, Neurology, 47, 1403, 10.1212/WNL.47.6.1403 · DOI · Paper page
- Merello, 1994, Extrapyramidisation in Alzheimer's disease: Prevalence, psychiatric and neuropsychological correlates, J Neurol Neurosurg Psychiatr, 57, 1503, 10.1136/jnnp.57.12.1503 · DOI
- Morris, 1996, Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias, J Neural Transm, 47, 205, 10.1007/978-3-7091-6892-9_14 · DOI
- Naimark, 1996, Psychotic symptoms in Parkinson's disease patients with dementia, J Am Geriatr Soc, 44, 296, 10.1111/j.1532-5415.1996.tb00918.x · DOI
- O'Brien, 1998, Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease, Neurobiol Aging, 19, S205
- Okazaki, 1961, Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadrapesis in flexion, J Neurol Neurosurg Psychiatr, 20, 237
- Papka, 1998, Diagnosing Lewy body disease: Accuracy of clinical criteria in detecting Lewy body pathology, Neurobiol Aging, 19, S203
- Pappert, 1999, Hallucinations, sleep fragmentation, and altered dream phenomenon in Parkinson's disease, Mov Disord, 14, 117, 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0 · DOI · Paper page
- Perry, 1993, Cholinergic transmitter and neurotrophic activities in Lewy body dementia: Similarity to Parkinson's and distinction from Alzheimer's disease, Alzheimer Dis Assoc Disord, 7, 69, 10.1097/00002093-199307020-00002 · DOI · Paper page
- Perry, 1990, Evidence of monaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia, J Neurochem, 55, 1454, 10.1111/j.1471-4159.1990.tb03162.x · DOI · Paper page
- Piggott, 1999, Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution, Brain, 122, 1449, 10.1093/brain/122.8.1449 · DOI · Paper page
- Piggott, 1994, Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity, Lancet, 343, 1044
- Rodriguez-Fernandez, 1998, Regional cerebral blood flow in patients with dementia with Lewy bodies, Neurobiol Aging, 19, S205
- Sahgal, 1992, A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types, Dementia, 3, 350
- Samuel, 1996, Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease, J Neuropathol Exp Neurol, 55, 44, 10.1097/00005072-199601000-00005 · DOI
- Shea, 1998, Donepezil for treatment of dementia with Lewy bodies: A case series of nine patients, Int Psychogeriatrics, 10, 229, 10.1017/S1041610298005341 · DOI · Paper page
- The Parkinson's Disease Study Group, 1999, Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease, New Engl J Med, 340, 757, 10.1056/NEJM199903113401003 · DOI · Paper page
- Trojanowski, 1998, Dementia with Lewy bodies: Histochemical aspects of differential diagnosis, Neurobiol Aging, 19, S4
- Walker, 2000, Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease and vascular dementia, Neurology, 54, 1616, 10.1212/WNL.54.8.1616 · DOI · Paper page
- Walker, 1997, Neuropsychological performance in Lewy body dementia and Alzheimer's disease, Br J Psychiatr, 170, 156, 10.1192/bjp.170.2.156 · DOI
- Walker, 1999, In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies, Lancet, 354, 646, 10.1016/S0140-6736(99)01178-2 · DOI
- Walker, 1999, Olanzapine in dementia with Lewy bodies: A clinical study, Int J Geriatr Psychiatr, 14, 459, 10.1002/(SICI)1099-1166(199906)14:6<459::AID-GPS957>3.0.CO;2-R · DOI
- Wolters, 1996, Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease, Neurology, 47, 1085, 10.1212/WNL.47.4.1085 · DOI · Paper page
- Woodard, 1962, Concentric hyaline inclusion body formation in mental disease: Analysis of twenty-seven cases, J Neuropathol Exp Neurol, 21, 442, 10.1097/00005072-196207000-00012 · DOI
- Zoldan, 1993, Ondansetron for hallucinosis in advanced Parkinson's disease, Lancet, 341, 562, 10.1016/0140-6736(93)90327-D · DOI
Cited by
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationSpencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis, S. J. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033530 · Cited by 551
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease
Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.010 · Cited by 542
Metadata
- Authors
- McKeith, I. G., & Burn, D.
- Venue
- Neurologic Clinics
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 18
- Issue
- 4
- Pages
- 865-883
- ISSN
- 0733-8619 (ISSN-L)
- OpenAlex
- W2029315819
- Cited by
- 168
- References
- 3
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA. https://app.cochat.ai/papers/10.1016/s0733-8619(05)70230-9
- The paper
- McKeith, I. G., & Burn, D. (2000). SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(05)70230-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.